PL3110425T3 - Trwała kompozycja oftalmiczna przeznaczona zwłaszcza do leczenia zespołu suchego oka - Google Patents

Trwała kompozycja oftalmiczna przeznaczona zwłaszcza do leczenia zespołu suchego oka

Info

Publication number
PL3110425T3
PL3110425T3 PL15713215T PL15713215T PL3110425T3 PL 3110425 T3 PL3110425 T3 PL 3110425T3 PL 15713215 T PL15713215 T PL 15713215T PL 15713215 T PL15713215 T PL 15713215T PL 3110425 T3 PL3110425 T3 PL 3110425T3
Authority
PL
Poland
Prior art keywords
volatile
dry eye
ophthalmic composition
eye syndrome
treating dry
Prior art date
Application number
PL15713215T
Other languages
English (en)
Inventor
Fabrice Mercier
Léopold SCHMETTERER
Original Assignee
Laboratoires Théa
Medical University Of Vienna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Théa, Medical University Of Vienna filed Critical Laboratoires Théa
Publication of PL3110425T3 publication Critical patent/PL3110425T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL15713215T 2014-02-28 2015-03-02 Trwała kompozycja oftalmiczna przeznaczona zwłaszcza do leczenia zespołu suchego oka PL3110425T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1451662A FR3018045B1 (fr) 2014-02-28 2014-02-28 Composition ophtalmique remanente, notamment pour le traitement de la secheresse oculaire
EP15713215.0A EP3110425B1 (fr) 2014-02-28 2015-03-02 Composition ophtalmique rémanente, notamment pour le traitement de la sécheresse oculaire
PCT/FR2015/050499 WO2015136186A1 (fr) 2014-02-28 2015-03-02 Composition ophtalmique rémanente, notamment pour le traitement de la sécheresse oculaire

Publications (1)

Publication Number Publication Date
PL3110425T3 true PL3110425T3 (pl) 2020-03-31

Family

ID=50624806

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15713215T PL3110425T3 (pl) 2014-02-28 2015-03-02 Trwała kompozycja oftalmiczna przeznaczona zwłaszcza do leczenia zespołu suchego oka

Country Status (14)

Country Link
EP (1) EP3110425B1 (pl)
CY (1) CY1122457T1 (pl)
DK (1) DK3110425T3 (pl)
ES (1) ES2760523T3 (pl)
FR (1) FR3018045B1 (pl)
HR (1) HRP20192142T1 (pl)
HU (1) HUE047396T2 (pl)
LT (1) LT3110425T (pl)
PL (1) PL3110425T3 (pl)
PT (1) PT3110425T (pl)
RS (1) RS59721B1 (pl)
SI (1) SI3110425T1 (pl)
SM (1) SMT201900746T1 (pl)
WO (1) WO2015136186A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000008299A1 (it) * 2020-04-17 2021-10-17 Glycores 2000 Srl Composizione liquida oftalmica comprendente acido ialuronico lineare a basso peso molecolare
EP4039248B1 (en) * 2021-02-04 2026-01-28 Zaklady Farmaceutyczne Polpharma S.A. Ophthalmic composition
EP4218717A1 (en) 2022-02-01 2023-08-02 Laboratoires THEA Ophthalmic composition comprising resveratrol for treating dry eye syndrome
EP4719349A1 (en) 2023-05-29 2026-04-08 Technophage, Investigação e Desenvolvimento Em Biotecnologia, S.A. Ophthalmic compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004262777A (ja) * 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
CN1302812C (zh) * 2004-11-30 2007-03-07 中国海洋大学 含海藻糖和玻璃酸的眼部用药传递系统及其制备方法
TWI393567B (zh) * 2005-03-31 2013-04-21 博士倫公司 治療乾眼之組合物及相關之製造方法及使用方法
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
AU2007338210B2 (en) * 2006-12-22 2013-01-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of ophthalmic drugs
CN101691478A (zh) * 2009-09-25 2010-04-07 海昌隐形眼镜有限公司 含海藻糖的角膜接触镜护理组合物及其制备方法
CN101691479B (zh) * 2009-09-25 2013-01-16 海昌隐形眼镜有限公司 一种角膜接触镜保存液组合物及其制备方法
US20110319502A1 (en) * 2010-06-25 2011-12-29 Coffey Martin J Compositions and Methods for Enhancing Reduction of Spore-Forming Microorganisms
GB201017048D0 (en) * 2010-10-08 2010-11-24 Ucl Business Plc Composition

Also Published As

Publication number Publication date
DK3110425T3 (da) 2019-12-09
FR3018045A1 (fr) 2015-09-04
FR3018045B1 (fr) 2017-06-16
HRP20192142T1 (hr) 2020-02-21
SI3110425T1 (sl) 2020-01-31
WO2015136186A1 (fr) 2015-09-17
CY1122457T1 (el) 2021-01-27
HUE047396T2 (hu) 2020-04-28
LT3110425T (lt) 2019-12-10
ES2760523T3 (es) 2020-05-14
EP3110425A1 (fr) 2017-01-04
RS59721B1 (sr) 2020-01-31
SMT201900746T1 (it) 2020-01-14
PT3110425T (pt) 2019-12-11
EP3110425B1 (fr) 2019-11-13

Similar Documents

Publication Publication Date Title
SG10201913976SA (en) Ophthalmic composition
IL248804B (en) A water-based preparation for the treatment of dry eye
ZA201605635B (en) Machine dishwash composition
IL251028A0 (en) 17a,21-diesters of cortexolone for use in the treatment of tumors
ZA201703382B (en) Fabric treatment composition
EP3213723A4 (en) Device for treating dry eye syndrome and strengthening eyesight
PL3145511T3 (pl) Kompozycja do leczenia oka
PL4008329T3 (pl) Związki izoksazoliny do zastosowania w leczeniu demodekozy
EP3089748A4 (en) Treating ocular neovascularization
GB201619525D0 (en) Ophthalmic composition
IL250980A0 (en) Mucolytic agents for use in the treatment of pulmonary sarcoidosis
SG11201707117SA (en) Ophthalmic composition
PT3110425T (pt) Composição oftálmica não volátil, nomeadamente para o tratamento da secura ocular
SI3519050T1 (sl) Sestavki za zdravljenje očesnih obolenj
ZA201703701B (en) Ophthalmic composition
PT3229780T (pt) Composições oftálmicas para utilização no tratamento da síndrome de olhos secos
PL3194551T3 (pl) Stała kompozycja do traktowania tekstyliów
HK1240091A1 (en) Mucolytic agents for use in tretaing pulmonary sarcoidosis
HK1242571A1 (zh) 眼科组合物
GB201408384D0 (en) New treatment